TAYLOR SAFFORD: Open Payments
NPI 1588262372 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$524 in 33 payments from 7 companies in 2025. Trend: 2023 $650 · 2024 $291 · 2025 $524
Food & beverage: $525
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 17 | $252 |
| MAYNE PHARMA COMMERCIAL LLC | 7 | $91 |
| Biogen, Inc. | 3 | $67 |
| Sumitomo Pharma America, Inc. | 2 | $37 |
| Baxter Healthcare | 1 | $34 |
| Exeltis, USA Inc. | 2 | $30 |
| Novo Nordisk Inc | 1 | $14 |
Products named: Veozah, ZURZUVAE, MYFEMBREE, PERCLOT, SLYND, Wegovy.
Industry payments across GA — which companies pay providers there.
